Laminin, hyaluronan, tenascin-C and type VI collagen levels in sera from patients with malignant melanoma

被引:32
作者
Burchardt, ER
Hein, R
Bosserhoff, AK
机构
[1] Univ Regensburg, Inst Pathol, D-93053 Regensburg, Germany
[2] FibroSys, Wuppertal, Germany
[3] Univ Witten Herdecke, Inst Clin Pharmacol, Witten, Germany
[4] Tech Univ Munich, Dept Dermatol, D-8000 Munich, Germany
关键词
D O I
10.1046/j.1365-2230.2003.01326.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
In this study, hyaluronan, laminin-1, tenascin-C and type VI collagen were measured in the sera of patients with stage I/II and stage IV melanoma. A significant increase in the serum levels of all four extracellular matrix proteins was found in patients with stage IV melanoma compared to healthy donors. Type VI collagen and hyaluronan serum levels were also significantly increased in stage I/II melanoma. Increased expression of the four matrix proteins was also demonstrated in melanoma cell lines using reverse transcriptase - polmerase chain reaction (RT-PCR) and enzyme-linked immunosorbent assay ( ELISA). We suggest that tenascin-C, hyaluronan, laminin-1 and type VI collagen are involved in melanoma development and extracellular matrix remodelling during melanoma progression. This finding will be of interest in the development of serum markers for progression of malignant melanoma.
引用
收藏
页码:515 / 520
页数:6
相关论文
共 34 条
[1]   Laminins: A family of diverse multifunctional molecules of basement membranes [J].
Aumailley, M ;
Krieg, T .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1996, 106 (02) :209-214
[2]   Fibrillary co-deposition of laminin-5 and large unspliced tenascin-C in the invasive front of oral squamous cell carcinoma in vivo and in vitro [J].
Berndt, A ;
Borsi, L ;
Hyckel, P ;
Kosmehl, H .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2001, 127 (05) :286-292
[3]   Expression of different extracellular matrix components in human brain tumor and melanoma cells in respect to variant culture conditions [J].
Bouterfa, H ;
Darlapp, AR ;
Klein, E ;
Pietsch, T ;
Roosen, K ;
Tonn, JC .
JOURNAL OF NEURO-ONCOLOGY, 1999, 44 (01) :23-33
[4]  
Chen HB, 2001, ANTICANCER RES, V21, P505
[5]   Serum hyaluronan in patients with multiple myeloma: Correlation with survival and Ig concentration [J].
Dahl, IMS ;
Turesson, I ;
Holmberg, E ;
Lilja, K .
BLOOD, 1999, 93 (12) :4144-4148
[6]  
Daniels KJ, 1996, LAB INVEST, V75, P55
[7]   SERUM HYALURONAN (HYALURONIC-ACID) IN BREAST-CANCER PATIENTS [J].
DELPECH, B ;
CHEVALLIER, B ;
REINHARDT, N ;
JULIEN, JP ;
DUVAL, C ;
MAINGONNAT, C ;
BASTIT, P ;
ASSELAIN, B .
INTERNATIONAL JOURNAL OF CANCER, 1990, 46 (03) :388-390
[8]  
DICKNEITE G, 1985, BEHRING I MITT, V78, P159
[9]  
Dueck M, 1999, INT J CANCER, V82, P477, DOI 10.1002/(SICI)1097-0215(19990812)82:4<477::AID-IJC2>3.0.CO
[10]  
2-5